GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Cyclically Adjusted Price-to-FCF

Shanghai Kehua Bio-engineering Co (SZSE:002022) Cyclically Adjusted Price-to-FCF : 10.20 (As of Sep. 21, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Cyclically Adjusted Price-to-FCF?

As of today (2024-09-21), Shanghai Kehua Bio-engineering Co's current share price is ¥5.71. Shanghai Kehua Bio-engineering Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was ¥0.56. Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF for today is 10.20.

The historical rank and industry rank for Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:002022' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.39   Med: 37.79   Max: 189.06
Current: 10.12

During the past years, Shanghai Kehua Bio-engineering Co's highest Cyclically Adjusted Price-to-FCF was 189.06. The lowest was 9.39. And the median was 37.79.

SZSE:002022's Cyclically Adjusted Price-to-FCF is ranked better than
90.05% of 221 companies
in the Medical Devices & Instruments industry
Industry Median: 40.11 vs SZSE:002022: 10.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shanghai Kehua Bio-engineering Co's adjusted free cash flow per share data for the three months ended in Jun. 2024 was ¥-0.094. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.56 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Kehua Bio-engineering Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Cyclically Adjusted Price-to-FCF Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.23 33.84 25.21 15.16 18.43

Shanghai Kehua Bio-engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.31 14.00 18.43 13.83 10.01

Competitive Comparison of Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF falls into.



Shanghai Kehua Bio-engineering Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=5.71/0.56
=10.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kehua Bio-engineering Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Shanghai Kehua Bio-engineering Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.094/114.7809*114.7809
=-0.094

Current CPI (Jun. 2024) = 114.7809.

Shanghai Kehua Bio-engineering Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.074 98.900 0.086
201412 0.169 99.000 0.196
201503 0.095 99.900 0.109
201506 0.041 99.500 0.047
201509 0.114 100.500 0.130
201512 0.025 100.600 0.029
201603 -0.072 102.200 -0.081
201606 0.092 101.400 0.104
201609 0.094 102.400 0.105
201612 0.233 102.600 0.261
201703 0.060 103.200 0.067
201706 -0.091 103.100 -0.101
201709 -0.027 104.100 -0.030
201712 0.108 104.500 0.119
201803 -0.063 105.300 -0.069
201806 -0.006 104.900 -0.007
201809 -0.057 106.600 -0.061
201812 0.132 106.500 0.142
201903 -0.180 107.700 -0.192
201906 0.162 107.700 0.173
201909 0.203 109.800 0.212
201912 0.027 111.200 0.028
202003 -0.041 112.300 -0.042
202006 0.409 110.400 0.425
202009 0.683 111.700 0.702
202012 1.122 111.500 1.155
202103 0.566 112.662 0.577
202106 0.047 111.769 0.048
202109 0.492 112.215 0.503
202112 0.520 113.108 0.528
202203 -0.034 114.335 -0.034
202206 -0.015 114.558 -0.015
202209 1.632 115.339 1.624
202212 0.936 115.116 0.933
202303 -0.936 115.116 -0.933
202306 -0.531 114.558 -0.532
202309 -0.018 115.339 -0.018
202312 -0.083 114.781 -0.083
202403 -0.370 115.227 -0.369
202406 -0.094 114.781 -0.094

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Kehua Bio-engineering Co  (SZSE:002022) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Shanghai Kehua Bio-engineering Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co Headlines

No Headlines